ABVC BioPharma Inc.
November 16, 2023 at 11:09 am - by Joey Ramson
$ABVC gapped up a few weeks ago on a licensing agreement with AiBtl BioPharma for treatments of major depressive disorder and attention deficit hyperactivity disorder. It subsequently faded, but found support at $1 since then. It is the current leader in the Prism MarketView Mental Heath index today as of posting.
